You are here

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Alabama Research Center
Birmingham, Alabama, 35209 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Complicated Urinary Tract Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Acute pyelonephritis or other complicated urinary tract infection due to gram negative
pathogens

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- ileal loops or vesicoureteral reflux

- complete obstruction of any portion of urinary tract, perinephric or intrarenal
abscess.

- fungal urinary tract infection

- permanent indirect catheter or nephrostomy unless removed within 48 hours of study
entry

- history hypersensitivity to study medication

NCT00690378
Pfizer
Completed
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now